---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-22-000403"
form_type: "8-K"
ticker: "RDNT"
cik: "0000790526"
company_name: "RadNet, Inc."
filed_at: "2022-01-24T23:59:59+00:00"
generated_at: "2026-06-27T16:22:02.217948+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# RadNet acquires AI firms Aidence and Quantib for ~$95M combined; issues 2.1M shares

## Summary
- Aidence acquired for ~$50M (incl. $10M milestones); Quantib for ~$45M.
- Issued 1,141,234 shares for Aidence and 965,058 shares for Quantib to stakeholders.
- Adds AI for lung nodule (Aidence) and prostate/brain MRI (Quantib) to DeepHealth division.
- Quantib products have FDA 510(k) clearance; Aidence's Veye pending FDA approval.
- Dr. Gregory Sorensen to lead combined AI initiatives across all three entities.

## SEC filing metadata
- accession: 0001683168-22-000403
- form_type: 8-K
- ticker: RDNT
- cik: 0000790526
- company_name: RadNet, Inc.
- filed_at: 2022-01-24T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/790526/000168316822000403/0001683168-22-000403-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/790526/000168316822000403/radnet_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-22-000403
- JSON: https://secwatch.observer/filing/0001683168-22-000403.json
- Plain text: https://secwatch.observer/filing/0001683168-22-000403.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.